The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host-Pathogen Interactions

被引:16
作者
Stojanovic, Bojana S. [1 ,2 ]
Stojanovic, Bojan [1 ,3 ]
Milovanovic, Jelena [1 ,4 ]
Arsenijevic, Aleksandar [1 ]
Dimitrijevic Stojanovic, Milica [1 ,5 ]
Arsenijevic, Nebojsa [1 ]
Milovanovic, Marija [1 ]
机构
[1] Univ Kragujevac, Fac Med Sci, Ctr Mol Med & Stem Cell Res, Kragujevac 34000, Serbia
[2] Univ Kragujevac, Fac Med Sci, Dept Pathophysiol, Kragujevac 34000, Serbia
[3] Univ Kragujevac, Fac Med Sci, Dept Surg, Kragujevac 34000, Serbia
[4] Univ Kragujevac, Fac Med Sci, Dept Histol, Kragujevac 34000, Serbia
[5] Univ Kragujevac, Fac Med Sci, Dept Pathol, Kragujevac 34000, Serbia
关键词
galectin-3; viral infection; host-pathogen interactions; inflammation; therapeutic target; HUMAN-IMMUNODEFICIENCY-VIRUS; AIRWAY EPITHELIAL-CELLS; HIV-1 TAT PROTEIN; INFLUENZA-A VIRUS; MINUTE VIRUS; EXPRESSION; CANCER;
D O I
10.3390/ijms24119617
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Galectin-3 (Gal-3), a beta-galactoside-binding lectin, plays a pivotal role in various cellular processes, including immune responses, inflammation, and cancer progression. This comprehensive review aims to elucidate the multifaceted functions of Gal-3, starting with its crucial involvement in viral entry through facilitating viral attachment and catalyzing internalization. Furthermore, Gal-3 assumes significant roles in modulating immune responses, encompassing the activation and recruitment of immune cells, regulation of immune signaling pathways, and orchestration of cellular processes such as apoptosis and autophagy. The impact of Gal-3 extends to the viral life cycle, encompassing critical phases such as replication, assembly, and release. Notably, Gal-3 also contributes to viral pathogenesis, demonstrating involvement in tissue damage, inflammation, and viral persistence and latency elements. A detailed examination of specific viral diseases, including SARS-CoV-2, HIV, and influenza A, underscores the intricate role of Gal-3 in modulating immune responses and facilitating viral adherence and entry. Moreover, the potential of Gal-3 as a biomarker for disease severity, particularly in COVID-19, is considered. Gaining further insight into the mechanisms and roles of Gal-3 in these infections could pave the way for the development of innovative treatment and prevention options for a wide range of viral diseases.
引用
收藏
页数:24
相关论文
共 113 条
[1]   Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases [J].
Ahmed, Rakin ;
Anam, Khairul ;
Ahmed, Hafiz .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
[2]   KSHV downregulation of galectin-3 in Kaposi's sarcoma [J].
Alcendor, Donald J. ;
Knobel, Susan M. ;
Desai, Prashant ;
Zhu, Wen Q. ;
Vigil, Hollie E. ;
Hayward, Gary S. .
GLYCOBIOLOGY, 2010, 20 (05) :521-532
[3]   Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development [J].
Arsenijevic, Aleksandar ;
Stojanovic, Bojana ;
Milovanovic, Jelena ;
Arsenijevic, Dragana ;
Arsenijevic, Nebojsa ;
Milovanovic, Marija .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) :1-19
[4]  
Baykiz D, 2022, CLIN LAB, V68, P2483, DOI [10.7754/Clin.Lab.2022.220134), 10.7754/Clin.Lab.2022.220134]
[5]   Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples [J].
Biji, Abhijith ;
Khatun, Oyahida ;
Swaraj, Shachee ;
Narayan, Rohan ;
Rajmani, Raju S. ;
Sardar, Rahila ;
Satish, Deepshikha ;
Mehta, Simran ;
Bindhu, Hima ;
Jeevan, Madhumol ;
Saini, Deepak K. ;
Singh, Amit ;
Gupta, Dinesh ;
Tripathi, Shashank .
EBIOMEDICINE, 2021, 70
[6]   Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? [J].
Boasso, A. ;
Shearer, G. M. ;
Chougnet, C. .
JOURNAL OF INTERNAL MEDICINE, 2009, 265 (01) :78-96
[7]   THE GENE (LGALS3BP) ENCODING THE SERUM-PROTEIN 90K, ASSOCIATED WITH CANCER AND INFECTION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS, MAPS AT 17Q25 [J].
CALABRESE, G ;
SURES, I ;
POMPETTI, F ;
NATOLI, G ;
PALKA, G ;
IACOBELLI, S .
CYTOGENETICS AND CELL GENETICS, 1995, 69 (3-4) :223-225
[8]  
Caniglia John L, 2020, F1000Res, V9, P1078, DOI 10.12688/f1000research.25979.1
[9]   A potential role for Galectin-3 inhibitors in the treatment of COVID-19 [J].
Caniglia, John L. ;
Guda, Maheedhara R. ;
Asuthkar, Swapna ;
Tsung, Andrew J. ;
Velpula, Kiran K. .
PEERJ, 2020, 8
[10]   Galectin-3 Guides Intracellular Trafficking of Some Human Serotransferrin Glycoforms [J].
Carlsson, Michael C. ;
Bengtson, Per ;
Cucak, Helena ;
Leffler, Hakon .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (39) :28398-28408